EUVIMEDEUVIMED entdecken
Open Access

Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults

Sanyog G Shitole iD, Susan R Heckbert iD, Gregory M Marcus iD, Sanjiv J Shah iD, Nona Sotoodehnia iD, Jeremy D Walston iD, Alexander P Reiner iD, Russell P Tracy iD, Bruce M Psaty iD, Jorge R Kizer iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Sanyog G Shitole und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Section San Francisco Veterans Affairs Health Care System San Francisco CA USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Biomarkers, Inflammation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Available evidence supports the importance of inflammation in atrial fibrillation (AF) pathogenesis, yet general anti‐inflammatory therapies have failed to show benefit for prevention of the arrhythmia. Better understanding of the specific inflammatory pathways involved is necessary to advance therapeutics. Methods and Results We evaluated 9 circulating markers of inflammation measured by immunoassays and incidence of AF in a population‐based older cohort. Biomarkers included measures of general inflammation and the NLR (nucleotide‐binding oligomerization domain‐like receptor) family pyrin domain containing 3 inflammasome, TNF‐α (tumor necrosis factor α), monocyte activation markers, and sIL‐2 (soluble interleukin‐2). Among 5726 participants (median age 72 years), 1836 developed AF over median follow‐up of 11.5 years. After adjustment for conventional risk factors, 5 biomarkers were positively associated with incident AF: IL‐6 (interleukin‐6), hazard ratio (HR), 1.14 (95% CI, 1.07–1.21); hs‐CRP (high‐sensitivity C‐reactive protein), HR, 1.05 (95% CI, 1.01–1.09); white blood cell count, HR, 1.18 (95% CI, 1.04–1.35); sTNFR1 (soluble TNF receptor 1), HR, 1.21 (95% CI, 1.05–1.39); and sIL‐2Rα (sIL‐2 receptor α), HR, 1.16 (95% CI, 1.05–1.29) (all per doubling of biomarker). sCD14, sCD163, IL‐18, and IL‐1 receptor antagonist showed no association with AF. Upon concurrent adjustment for all biomarkers, only IL‐6 remained significantly associated with the arrhythmia, HR, 1.17 (95% CI, 1.07–1.26).

Conclusions

Among older adults, IL‐6, hs‐CRP, white blood cell count, sTNFR1, and sIL‐2Rα were positively associated with incident AF, but only IL‐6 retained significance on concurrent adjustment. These findings newly document associations for sTNFR1 and sIL‐2Rα and lend support to a preeminent role for IL‐6 in development of this arrhythmia. The efficacy of IL‐6 blockade for AF prevention awaits completion of appropriate clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationBiomarkersInflammationHumansAgedMaleFemaleIncidenceC-Reactive ProteinRisk FactorsInflammation MediatorsReceptors, Tumor Necrosis Factor, Type IInterleukin-6Aged, 80 and overAge FactorsTumor Necrosis Factor-alphaProspective StudiesInterleukin-2

Stichwörter der Autor:innen

atrial fibrillationinflammationolder adults

Substanzen

BiomarkersC-Reactive ProteinInflammation MediatorsReceptors, Tumor Necrosis Factor, Type IInterleukin-6Tumor Necrosis Factor-alphaInterleukin-2

Autor:innen und Institutionen

  • Cardiology Section San Francisco Veterans Affairs Health Care System San Francisco CA USA.
  • Department of Medicine University of California San Francisco San Francisco CA USA.
  • Department of Medicine Albert Einstein College of Medicine Bronx NY USA.
  • Department of Epidemiology University of Washington Seattle WA USA.
  • Department of Medicine Northwestern University Chicago IL USA.
  • Department of Medicine University of Washington Seattle WA USA.

ORCID-Profile: Sanyog G Shitole, Susan R Heckbert, Gregory M Marcus, Sanjiv J Shah, Nona Sotoodehnia, Jeremy D Walston, Alexander P Reiner, Russell P Tracy, Bruce M Psaty, Jorge R Kizer

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Shitole, S. G., Heckbert, S. R., Marcus, G. M., Shah, S. J., Sotoodehnia, N., Walston, J. D., Reiner, A. P., Tracy, R. P., Psaty, B. M., & Kizer, J. R. (2024). Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035710

Vancouver

Shitole SG, Heckbert SR, Marcus GM, Shah SJ, Sotoodehnia N, Walston JD, et al. Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035710

BibTeX
@article{Shitole2024,
  author = {Shitole, Sanyog G and Heckbert, Susan R and Marcus, Gregory M and Shah, Sanjiv J and Sotoodehnia, Nona and Walston, Jeremy D and Reiner, Alexander P and Tracy, Russell P and Psaty, Bruce M and Kizer, Jorge R},
  title = {Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035710}
}
Kostenlos starten →